For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, such therapies often remain ineffective. Now Japanese scientists are providing a possible way out: a combination of two bacteria that control each other and attack cancer even without the help of the immune system.
The new therapy could help above all those people whose immune system is exhausted after cancer therapy – and for whom there are hardly any treatment options so far.
Two microbes, one task
A research team led by Eijiro Miyako from the Japan Advanced Institute of Science and Technology has combined two natural bacterial species: Proteus mirabilis and Rhodopseudomonas palustris. In a ratio of three to 97 percent, they form a consortium that the researchers call "AUN" – after a Japanese term for harmony.
These two microbes behave like partners: Proteus mirabilis penetrates deep into tumor tissue and changes its shape there to attack cancer cells. Rhodopseudomonas palustris regulates the process and prevents the bacteria from getting out of control or triggering inflammation. This creates a finely balanced balance that destroys tumors from the inside out, but spares healthy tissue.
"After 150 years, a new chapter in bacteria-based cancer therapy is finally beginning," says study leader Miyako. He is alluding to the fact that scientists first researched bacterial cancer treatment 150 years ago.
"Suffocating" the tumor
In the study published in the journal Nature Biomedical Engineering, the scientists investigated what happens in the body when AUN enters the bloodstream. The bacteria find their way to the tumour and begin to change its blood supply. Small clots form in the fine vessels, which only occur in the tumour tissue. As a result, the cancer is cut off from oxygen – it "suffocates" from the inside.
At the same time, the bacteria form fibre-like structures with which they directly attack cancer cells. This combined effect leads to a massive necrosis, i.e. to the death of the tumour tissue.
Teamwork significantly increases the impact
The team found that a two-stage treatment is particularly effective: first a small dose to accustom the immune system to the bacteria, followed by a higher dose. This procedure led to a complete decrease in tumours in all experiments – while at the same time being well tolerated.
Hope even for weak patients
Classic immunotherapies, such as so-called checkpoint inhibitors or CAR-T cell therapies, only work when the body's own defences are intact. In people who have already had several chemotherapy treatments, they usually remain unsuccessful. This is exactly where the new concept cats in: The bacteria attack tumours independently of Defence cells.
In the study, the researchers reported:
AUN completely eliminated tumours – even in animals whose immune system was barely active.
This opens up a completely new way of treatment for patients who have previously had no chance of immunotherapy.
No genetically modified microbes
Particularly remarkable: The researchers did not have to genetically modify the microbes. Both species exist in nature – Proteus mirabilis can also be found in small quantities in the human body, Rhodopseudomonas palustris in soils and waters.
They adapt in the tumour environment: one bacterium becomes more mobile and aggressive, the other ensures that the attack remains targeted. If unwanted reactions occur, the system can be stopped with common antibiotics. This could make the use for patients one day much safer than previous bacterial therapies.
Clinical study planned
The method is not yet approved for clinical practice. The team around Miyako is currently preparing the first studies with humans. In the coming years, safety, dosage and efficacy are to be tested.
The goal is to develop a therapy that fights tumours regardless of the state of the immune system. If this succeeds, AUN therapy could create a new treatment option – for those patients who previously had no hope of recovery.
Summary:
- A Japanese study shows that two naturally occurring bacteria can destroy cancer without needing the immune system.
- The bacteria specifically block the blood supply to cancer cells and trigger their death, while healthy cells are spared.
- The method is considered a hope for patients whose immune system is severely weakened after chemotherapy or radiation therapy.
Von Anne Bajrica
The original of this article "New bacterial therapy destroys cancer even with a weakened immune system" comes from Smart Up News.
News
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]
Scientists Have Discovered These Deadly Parasites Are Secretly Swapping DNA
Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread. A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than [...]
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]
What Bundibugyo Ebola vaccines and treatments are under development
By Mariam Sunny and Jennifer Rigby May 29 (Reuters) – Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the [...]
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]















